Fiscal Year End Company Status Exempt Flag December 31 Trading N Board of Directors Name Position David Howard  Director of the Board Louis Lacasse  Director of the Board Richard Whittall  Director of the Board Stuart MacGregor  Director of the Board W. Hugh Notman  President   Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 22/Nov/1995    Canada  British Columbia    Exchange Filing Office Location Vancouver Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development  'Research and Development Biotech' company.  Securities Symbol Security Name Market Status CYX Calyx Bio-Ventures Inc TSX Venture TRADING Name History From To Calyx Bio-Ventures Inc. 17/Sep/2008 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR Not Received Associations Auditing Firm:  Ernst & Young, Chartered Accountants Investor Relations:  Mammoth Market Advisory Corp. Law Firm:  Stikeman Elliot LLP (Calgary) Transfer Agent:  Computershare Investor Services Inc.
Latest Information Type Date Title News Releases  15/May/2013  NEWS RELEASE - COMMERCIAL LAUNCH OF HIGHER YIELDING VARIETY OF[MARKET NEWS]     NEWS RELEASE - CALYX ANNOUNCES COMMERCIAL LAUNCH OF HIGHER YIELDING VARIETY OF RESONANCE(R) CARINATA[MARKETWIRE]     NEWS RELEASE - CALYX PROVIDES UPDATE ON 2013 RESONANCE(R) CARINATA CONTRACTING PROGRAM[MARKETWIRE] Bulletins  22/Jan/2013  PP-B Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data